These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28819432)

  • 1. Silencing of
    Cao R; Wang G; Qian K; Chen L; Qian G; Xie C; Dan HC; Jiang W; Wu M; Wu CL; Xiao Y; Wang X
    J Cancer; 2017; 8(12):2282-2295. PubMed ID: 28819432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Holliday junction‑recognition protein modulates apoptosis, cell cycle arrest and reactive oxygen species stress in human renal cell carcinoma.
    Yuan JS; Chen ZS; Wang K; Zhang ZL
    Oncol Rep; 2020 Sep; 44(3):1246-1254. PubMed ID: 32582972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of
    Hu Q; Wang G; Peng J; Qian G; Jiang W; Xie C; Xiao Y; Wang X
    Biomed Res Int; 2017; 2017():3781904. PubMed ID: 29147649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARγ-SIRT1 feedback loop in human bladder cancer cells.
    Cao R; Wang G; Qian K; Chen L; Ju L; Qian G; Wu CL; Dan HC; Jiang W; Wu M; Xiao Y; Wang X
    Cancer Lett; 2018 Feb; 414():278-293. PubMed ID: 29175458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway.
    Wang G; Cao R; Wang Y; Qian G; Dan HC; Jiang W; Ju L; Wu M; Xiao Y; Wang X
    Sci Rep; 2016 Oct; 6():35783. PubMed ID: 27779188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Holliday Junction-Recognition Protein-Mediated C-Jun N-Terminal Kinase/ Signal Transducer and Activator of Transcription 3 Signaling Pathway on Cell Proliferation, Cell Cycle and Cell Apoptosis in Bladder Urothelial Carcinoma.
    Gao S; Zhou XQ; Wu Q; Chen XD; Li P; Qin YM
    Tohoku J Exp Med; 2023 Feb; 259(3):209-219. PubMed ID: 36543245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0/G1 phase of bladder cancer cells.
    Chen L; Wang G; Luo Y; Wang Y; Xie C; Jiang W; Xiao Y; Qian G; Wang X
    Int J Oncol; 2017 Jan; 50(1):263-271. PubMed ID: 27922670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HJURP inhibits proliferation of ovarian cancer cells by regulating CENP-A/CENP-N.
    Zhang Y; Zhang W; Sun L; Yue Y; Shen D; Tian B; Du M; Dong M; Liu Y; Zhang D
    Bull Cancer; 2022 Oct; 109(10):1007-1016. PubMed ID: 35940943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in holliday junction recognition protein (HJURP): Structure, molecular functions, and roles in cancer.
    Li L; Yuan Q; Chu YM; Jiang HY; Zhao JH; Su Q; Huo DQ; Zhang XF
    Front Cell Dev Biol; 2023; 11():1106638. PubMed ID: 37025176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
    Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
    Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARγ-mediated pathway in bladder cancer.
    Cheng S; Wang G; Wang Y; Cai L; Qian K; Ju L; Liu X; Xiao Y; Wang X
    Clin Sci (Lond); 2019 Aug; 133(15):1745-1758. PubMed ID: 31358595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role and function of PPARγ in bladder cancer.
    Peng T; Wang G; Cheng S; Xiong Y; Cao R; Qian K; Ju L; Wang X; Xiao Y
    J Cancer; 2020; 11(13):3965-3975. PubMed ID: 32328200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Holliday junction-recognizing protein promotes cell proliferation and correlates with unfavorable clinical outcome of hepatocellular carcinoma.
    Hu B; Wang Q; Wang Y; Chen J; Li P; Han M
    Onco Targets Ther; 2017; 10():2601-2607. PubMed ID: 28553125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
    Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
    Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyl-coenzyme A: cholesterol acyltransferase inhibitor avasimibe suppresses tumorigenesis and induces G1-phase cell-cycle arrest by activating PPARγ signaling pathway in bladder cancer.
    Peng T; Xiong K; He Z; Cheng S; Chen S; Chen S; Yang Z; Xiang W; Ju L; Zhang Y; Qian K; Xiao Y; Wang G
    J Cancer; 2024; 15(2):370-382. PubMed ID: 38169575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Holliday junction recognition protein as a prognostic biomarker and therapeutic target for oral cancer.
    Tsevegjav B; Takano A; Zhu M; Yoshitake Y; Shinohara M; Daigo Y
    Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35103286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines.
    Yang YC; Tsao YP; Ho TC; Choung IP
    Int J Gynecol Cancer; 2007; 17(2):418-25. PubMed ID: 17316361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPM8 Inhibition Regulates the Proliferation, Migration and ROS Metabolism of Bladder Cancer Cells.
    Wang G; Cao R; Qian K; Peng T; Yuan L; Chen L; Cheng S; Xiong Y; Ju L; Wang X; Xiao Y
    Onco Targets Ther; 2020; 13():8825-8835. PubMed ID: 32943886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of Holliday junction recognition protein predicts poor prognosis and biochemical recurrence in patients with prostate cancer.
    Chen YF; Liang YX; Yang JA; Yuan DZ; Li J; Zheng SS; Wan YP; Wang B; Han ZD; Zhong WD
    Oncol Lett; 2019 Dec; 18(6):6697-6703. PubMed ID: 31814851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.